Krsnaa Diagnostics Limited has released the audio recording of its earnings conference call for the third quarter of fiscal year 2026, covering the period ended December 31, 2025. The company has fulfilled its regulatory disclosure obligations by making the recording publicly available and notifying stock exchanges.

Earnings Call Details

The earnings conference call was conducted on February 06, 2026, at 12:30 hours IST through digital means. The call covered the company's financial performance for both the quarter and nine months ended December 31, 2025.

Regulatory Compliance

The disclosure has been made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Sujoy Sudipta Bose signed the regulatory filing dated February 06, 2026.

Access Information

The audio recording is accessible through the company's official website under the investor relations section. The recording link has been provided to facilitate stakeholder access to the earnings discussion and management commentary on quarterly performance.

The company has notified both BSE Limited and National Stock Exchange of India Limited about the availability of the earnings call recording, ensuring compliance with listing requirements and providing transparency to investors and stakeholders.

Krsnaa Diagnostics has announced its Q3FY26 financial results for the quarter ended December 31, 2025, showing revenue growth alongside declining profitability. The healthcare diagnostics company reported mixed performance with consolidated net profit of ₹152.46 million compared to ₹194.15 million in the same quarter of the previous year, representing a year-over-year decrease of 21.48%.

Financial Performance Overview

The company's Q3FY26 results demonstrate contrasting trends across key financial metrics. While consolidated revenue showed positive momentum, net profitability faced significant headwinds during the quarter.

Revenue Performance Analysis

Krsnaa Diagnostics achieved consolidated revenue from operations of ₹1,812.01 million in Q3FY26, marking growth from ₹1,745.12 million recorded in the corresponding quarter of the previous year. This revenue expansion of 3.84% reflects the company's continued market presence in the healthcare diagnostics sector.

However, standalone revenue from operations declined to ₹1,594.32 million from ₹1,651.57 million year-over-year, indicating mixed performance across different business segments.

Nine-Month Performance Metrics

For the nine months ended December 31, 2025, the company demonstrated stronger overall performance with consolidated revenue reaching ₹5,801.70 million compared to ₹5,310.84 million in the corresponding period last year, representing growth of 9.24%.

Tax Assessment Challenges

The company continues to face ongoing tax assessment proceedings following search operations conducted under sections 132(1) and 133A of the Income Tax Act, 1961. The Income Tax authorities have raised a total demand of ₹513.86 million across multiple assessment years from AY 2017-18 to AY 2023-24.

Krsnaa Diagnostics has filed appeals against these assessment orders and paid ₹102.77 million under protest. The company received additional show cause notices dated January 7, 2026, for AY 2018-19 and AY 2019-20, and has submitted preliminary information in response.

Earnings Per Share Performance

The company's earnings per share metrics reflect the profit decline, with consolidated basic EPS for Q3FY26 at ₹4.72 compared to ₹6.01 in the same quarter last year. For the nine-month period, consolidated basic EPS improved to ₹18.45 from ₹17.63 year-over-year, indicating better cumulative performance despite quarterly challenges.